Advertisement
ResearchIn-Press PreviewGeneticsOncology
Open Access |
10.1172/JCI195334
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by Grandis, J. in: PubMed | Google Scholar
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by Li, H. in: PubMed | Google Scholar
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by Harrison, B. in: PubMed | Google Scholar
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by Webster, A. in: PubMed | Google Scholar
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by Pucilowska, J. in: PubMed | Google Scholar
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by Nguyen, A. in: PubMed | Google Scholar
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by Lee, J. in: PubMed | Google Scholar
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by
Mills, G.
in:
PubMed
|
Google Scholar
|
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by Gencel-Augusto, J. in: PubMed | Google Scholar
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by Zeng, Y. in: PubMed | Google Scholar
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by Long, S. in: PubMed | Google Scholar
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by
Kim, M.
in:
PubMed
|
Google Scholar
|
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by
Lee, R.
in:
PubMed
|
Google Scholar
|
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by Kutler, D. in: PubMed | Google Scholar
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by
Scognamiglio, T.
in:
PubMed
|
Google Scholar
|
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by Brandwein-Weber, M. in: PubMed | Google Scholar
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by Urken, M. in: PubMed | Google Scholar
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by Khodos, I. in: PubMed | Google Scholar
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by
de Stanchina, E.
in:
PubMed
|
Google Scholar
|
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by Lin, Y. in: PubMed | Google Scholar
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by Donovan, F. in: PubMed | Google Scholar
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by Chandrasekharappa, S. in: PubMed | Google Scholar
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by
Jung, M.
in:
PubMed
|
Google Scholar
|
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by Sanders, M. in: PubMed | Google Scholar
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by
Smogorzewska, A.
in:
PubMed
|
Google Scholar
|
1Department of Otolaryngology – Head and Neck Surgery, University of California San Francisco, San Francisco, United States of America
2Laboratory of Genome Maintenance, The Rockefeller University, New York, United States of America
3Immune Monitoring and Omics Lab, Knight Cancer Institute, Oregon Health Sciences University, Portland, United States of America
4Department of Pathology, University of California San Francisco, San Francisco, United States of America
5Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States of America
6Department of Otolaryngology – Head and Neck Surgery, Weill Cornell Medical College, New York, United States of America
7Department of Pathology, Weill Cornell Medical College, New York, United States of America
8Department of Pathology, Icahn School of Medicine at Mt. Sinai, New York, United States of America
9Department of Otolaryngology – Head and Neck Surgery, Icahn School of Medicine at Mt. Sinai, New York, United States of America
10Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, United States of America
11National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America
12Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
Find articles by
Johnson, D.
in:
PubMed
|
Google Scholar
|
Published December 16, 2025 - More info
Fanconi anemia (FA) confers a high risk (~700-fold increase) of solid tumor formation, most often head and neck squamous cell carcinoma (HNSCC). FA germline DNA repair defects preclude administration of most chemotherapies and prior hematopoietic stem cell transplantation limits use of immunotherapy. Thus, surgery and judicious delivery of radiation offer the only treatment options, with most patients succumbing to their cancers. A paucity of preclinical models has limited the development of new treatments. Here, we report, to our knowledge, the first patient-derived xenografts (PDXs) of FA-HNSCC and highlight the efficacy of FDA-approved EGFR targeted therapies in tumors with high EGFR/p-EGFR levels and the activity of the FDA-approved Bcl-2 inhibitor venetoclax in a FA-HNSCC PDX overexpressing Bcl-2. These findings support the development of precision medicine approaches for FA-HNSCC.